Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Risk Score for Asthma Exacerbation (RSE)

    Predicts likelihood of asthma exacerbation within 6 months.
    Favorite
    When to Use
    Pearls/Pitfalls
    Why Use

    Patients with poorly-controlled asthma.

    • The Risk Score for Asthma Exacerbation (RSE) suggests which patients will experience an asthma exacerbation within 6 months.
    • The RSE should be further studied - while its validation was large, it was not validated outside of its own derivation cohort.
    • It was developed from pharmaceutical trials of patients with poorly controlled asthma, so it may not be applicable to patients with milder asthma severity.

    A score to help determine likelihood of exacerbation may assist in guiding therapy and/or monitoring.

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Advice

    The RSE has been developed from a large cohort and now requires testing through validation studies.

    Formula

    Addition of assigned points.

    Facts & Figures

    Score interpretation:

    RSE Score Likelihood of exacerbation in 6 months
    0-10 5%
    11-20 5-7%
    21-30 7-10%
    31-40 10-12%
    41-50 12-15%
    51-60 15-18%
    61-70 18-24%
    71-80 24-30%
    81-90 30-37%
    91-100 37-45%

    For more information on the Global Initiative for Asthma treatment steps, click here.

    Dr. Eric Bateman

    About the Creator

    Eric Bateman, MD, is a clinician-scientist at the University of Capetown in South Africa. He is the founder of the University of Cape Town Lung Institute and served as its director for 16 years until 2016. He is now a member of several editorial boards for international respiratory journals and has authored more than 300 papers.

    To view Dr. Eric Bateman's publications, visit PubMed